You are here: Industry Insights > Cancer

News List

Full Chemo Doses May Improve Survival in Breast Cancer drugs
September 12, 2019
Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer patients...
Nkarta raises $114m to bring cancer therapies into clinic pharmaceutical-technology
September 10, 2019
US-based biopharmaceutical firm Nkarta Therapeutics has raised $114m in series B funding round to advance its natural killer (NK) cell-based cancer drug candidates into clinical trials.
EMA to review Picato after rise in skin cancer cases europeanpharmaceuticalreview
September 09, 2019
The EMA will assess the marketing authorisation for the medication to see whether it is a cause of skin cancer in patients.
Incidence of Colorectal Cancer Up in Younger Adults Worldwide drugs
September 09, 2019
Among younger adults, colorectal cancer (CRC) incidence rates have increased in several countries, according to a study published online in Gut.
Colon Cancer Rates Rising Among the Young in Wealthy Nations drugs
September 06, 2019
Colon cancer rates among young adults are on the rise in the United States, Canada and seven other wealthy nations, even though rates among older adults are down or stable, a new study finds.
PTSD a Risk Factor for Ovarian Cancer? drugs
September 06, 2019
Struggling with post-traumatic stress disorder (PTSD) may make a woman more vulnerable to ovarian cancer, a new study suggests.
Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer worldpharmanews
September 05, 2019
AstraZeneca announced that it has received marketing authorisation from China's National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for adults with locally-advanced...
Mylan generic of lung cancer drug Alimta approved europeanpharmaceuticalreview
September 04, 2019
Mylan NV’s generic version Eli Lilly and Co’s lung cancer drug, Alimta, has been given tentative approval by the FDA.
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer drugs
September 04, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians offer risk-reducing medications to women at increased risk for breast cancer and at low risk for adverse medication effects.
Chemotherapy is Out-of-date? Global Chemotherapy Demands will be Doubled in 2040, with China Having the Highest Demands! PharmaSources/Yefenghong
September 04, 2019
Many people consider that the status of chemotherapy in cancer treatment has fallen considerably and some even consider chemotherapy to be out-of-date in recent years with the occurrence of targeted drugs and immunotherapy. Is chemotherapy useless?

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page